; (2) the acquisition or provision of health care services overseas for— (A) employees of the United States, including members of the uniformed services (as defined in section 101(a) of title 10, United States Code), whose official duty stations are located overseas; or (B) employees of contractors or subcontractors of the United States— (i) who are performing under a contract that directly supports the missions or activities of individuals described in subparagraph (A); and (ii) whose primary duty stations are located overseas; or (3) the acquisition, use, or distribution of genetic sequencing data, however complied, that is commercially available. (f) Evaluation of certain biotechnology entities Not later than 90 days after the date of the enactment of this Act, the Secretary of Defense shall determine whether Wuxi AppTec, AxBio, and any subsidiary, affiliate, or successor of such entities, or any other entity headquartered in or organized under the laws of the People’s Republic of China is a biotechnology company of concern. (g) Regulations (1) Guidance Not later than 180 days after the date of the enactment of this Act, the Director of the Office of Management and Budget, in coordination with the Federal Acquisition Security Council, the Federal Acquisition Regulatory Council, the Secretary of Defense, and other heads of Executive agencies as determined appropriate by the Director of the Office of Management and Budget, shall establish guidance, as necessary, to implement the requirements of this section. (2) Federal Acquisition Regulation Not later than 270 days after the date of the enactment of this Act, the Federal Acquisition Regulatory Council shall revise the Federal Acquisition Regulation as necessary to implement the requirements of this section. (h) Definitions In this section: (1) Appropriate congressional committees The term appropriate congressional committees means— (A) the Committee on Armed Services and the Committee on Homeland Security and Governmental Affairs of the Senate